Akèy › Lukemi miyoyid nan faz kwonik › Kalifòni
Etid klinik pou Lukemi miyoyid nan faz kwonik nan Kalifòni
5 etid pou Lukemi miyoyid nan faz kwonik ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1062, Duarte
- Ascentage Investigative Site #1099, Irvine
- Ascentage Investigative Site #1075, La Jolla
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06423911A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Stockton Hematology Oncology Medical Group Inc, Stockton
- Lundquist Inst BioMed at Harbor, Torrance
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Jul 20, 2026 · NCT07091019Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 10, 2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- UC Irvine Health, Orange
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT06163430Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.